Japan has set reimbursement prices for six new drugs under its national health insurance (NHI) scheme - including a gene therapy with the second-highest unit price ever for a therapeutic product in the country - along with one-off price cuts for several other drugs that have shown higher than expected growth.
The Ministry of Health, Labour and Welfare (MHLW) announced that the products set to be added to the NHI reimbursement...






